<DOC>
	<DOCNO>NCT02586545</DOCNO>
	<brief_summary>The aim study test effect new share care model type 2 diabetes care compare standardize care management program specialize hospital-based out-patient clinic . The hypothesis participant type 2 diabetes follow share care program comparable outcome HbA1c participant receive standard care .</brief_summary>
	<brief_title>Shared Care Patients With Type 2 Diabetes Across Primary Secondary Health Care Sector</brief_title>
	<detailed_description>The prevalence patient type 2 diabetes growth globally . In order secure high quality diabetes care necessary rethink way care organize . The investigator want test new model share care across interface primary secondary care sector patient type 2 diabetes risk stratification level 2 . Based national regional risk stratification model patient stratify three level accord risk complexity treatment : level 1 ( uncomplicated ) , level 2 ( intermediate risk ) level 3 ( high risk ) . The objective study show equal outcome among participant treat either share care program establish program specialize outpatient clinic . The study non-inferiority randomize controlled trial . The share care model test period three year . All participant offer four medical visit year . The share care intervention consist one annual comprehensive check-up outpatient clinic three quarterly visit general practice . The control group follow four quarterly visit outpatient clinic include annual comprehensive check-up . The recruitment period span approximately 12 month , participant randomize intervention control group 1:1 ratio .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<criteria>Must age 18 year The diagnosis type 2 diabetes Risk stratification level 2 Capable speak write Danish Give oral write consent enter study Diagnosed type diabetes type 2 diabetes Risk stratification level 1 3 Being pregnant breastfeed Having severe comorbidity life expectancy less five year Being condition , patient able show go appointment ( e.g . moderate severe dementia severe psychiatric condition ) Participating longlasting intervention ( &gt; 2 week ) potentially affect primary outcome study patient participate study include blood sample amount &gt; 5 % blood volume two month prior randomisation and/or followup visit</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>